Cargando…

Role of CD5L and SRD5A2 as Prognostic Biomarkers for Hepatocellular Carcinoma

PURPOSE: Due to the limitations of currently available biomarkers, new biomarkers are needed to accurately predict the prognosis of patients with hepatocellular carcinoma (HCC) patients. METHODS: In this study, we screened for differentially expressed genes (DEGs) in the tumor and the adjacent tissu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Yunxiu, Huang, Xiaopeng, Zhan, Jiabin, Zhang, Shuai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646114/ https://www.ncbi.nlm.nih.gov/pubmed/34880664 http://dx.doi.org/10.2147/IJGM.S337769

Ejemplares similares

Evaluation of the Clinical Efficacy of Intensity-Modulated Radiotherapy Combined with Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma with Extrahepatic Oligometastasis and Prognostic Factors for Patient Survival
por: Luo, Yunxiu, et al.
Publicado: (2023)

Over-expression of SRD5A3 and its prognostic significance in breast cancer
por: Zhang, Yong-ping, et al.
Publicado: (2021)

Steroid 5 alpha-reductase 3 (SRD5A3) promotes tumor growth and predicts poor survival of human hepatocellular carcinoma (HCC)
por: Mai, Qicong, et al.
Publicado: (2020)

Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels
por: Rył, Aleksandra, et al.
Publicado: (2017)

Overexpression of SRD5A3 in Hepatocellular Carcinoma and Its Molecular Mechanism: A Study of Bioinformatics Exploration Analysis with Experimental Verification
por: Chen, Erbao, et al.
Publicado: (2022)

Adult phenotype and further phenotypic variability in SRD5A3-CDG
por: Kara, Bülent, et al.
Publicado: (2014)

Homozygous Ala65Pro Mutation with V89L Polymorphism in SRD5A2 Deficiency
por: Eren, Erdal, et al.
Publicado: (2016)

Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma
por: Lewis, Michael J, et al.
Publicado: (2004)

AB215. Variants in the SRD5A2 gene are associated with quality of semen
por: Zhao, Dan, et al.
Publicado: (2014)

A novel pathogenic variant of SRD5A2 in an Iranian psuedohermaphrodite male
por: Dalili, Setilla, et al.
Publicado: (2020)

SRD5A3-CDG: Emerging Phenotypic Features of an Ultrarare CDG Subtype
por: Kamarus Jaman, Nazreen, et al.
Publicado: (2021)

Role of CD5 molecular-like on hepatocellular carcinoma
por: Gao, Zhaowei, et al.
Publicado: (2023)

SRD5A3 defective congenital disorder of glycosylation: clinical utility gene card
por: Jaeken, Jaak, et al.
Publicado: (2020)

Crystal structure of steroid reductase SRD5A reveals conserved steroid reduction mechanism
por: Han, Yufei, et al.
Publicado: (2021)

Srd5a1 is Differentially Regulated and Methylated During Prepubertal Development in the Ovary and Hypothalamus
por: Bar-Sadeh, Ben, et al.
Publicado: (2023)

Identification of three novel SRD5A2 mutations in Chinese patients with 5α-reductase 2 deficiency
por: Cheng, Tong, et al.
Publicado: (2019)

HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma
por: Xue, Feng, et al.
Publicado: (2015)

CD69 serves as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma
por: Tang, Kaihua, et al.
Publicado: (2023)

SSRP1 Is a Prognostic Biomarker Correlated with CD8(+) T Cell Infiltration in Hepatocellular Carcinoma (HCC)
por: Luo, Guanshui, et al.
Publicado: (2021)

Characterising SRD5A2 Gene Variants in 37 Indonesian Patients with 5-Alpha-Reductase Type 2 Deficiency
por: Marzuki, Nanis S., et al.
Publicado: (2019)

SRD: a Staphylococcus regulatory RNA database
por: Sassi, Mohamed, et al.
Publicado: (2015)

Eg5 as a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular Carcinoma
por: Shao, Yu-Yun, et al.
Publicado: (2021)

G Protein-Coupled Receptor Kinase 4 Is a Novel Prognostic Factor in Hepatocellular Carcinoma
por: Luo, Yunxiu, et al.
Publicado: (2022)

The association of 5-alpha reductase type 2 (SRD5A2) gene polymorphisms with prostate cancer in a Korean population
por: Choi, Se Young, et al.
Publicado: (2015)

Polymorphisms of HPC2/ELAC2 and SRD5A2 (5α-Reductase Type II) Genes in Prostate Cancer
por: İzmirli, M, et al.
Publicado: (2011)

Longer TA repeat but not V89L polymorphisms in the SRD5A2 gene may confer acne risk in the Chinese population
por: Hu, Xue, et al.
Publicado: (2018)

Expression of CSF1, AR, and SRD5A2 during Postnatal Development of the Boar Reproductive Tract
por: Katleba, Kimberley, et al.
Publicado: (2022)

A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland
por: Mononen, N, et al.
Publicado: (2001)

Evidence for an Association between the SRD5A2 (Type II Steroid 5α-Reductase) Locus and Prostate Cancer in Italian Patients
por: Margiotti, K., et al.
Publicado: (2000)

Effects on Steroid 5-Alpha Reductase Gene Expression of Thai Rice Bran Extracts and Molecular Dynamics Study on SRD5A2
por: Khantham, Chiranan, et al.
Publicado: (2021)

Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma
por: Cai, Xiaopeng, et al.
Publicado: (2021)

G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma
por: Wang, Hang, et al.
Publicado: (2022)

Identification of a case of SRD5A3-congenital disorder of glycosylation (CDG1Q) by exome sequencing
por: Gupta, Neerja, et al.
Publicado: (2018)

Molecular Characterization of Two Known SRD5A2 Gene Variants in Mexican Patients With Disorder of Sexual Development
por: María Guadalupe, Ortiz-López, et al.
Publicado: (2022)

A rare case of SRD5A3‐CDG in a patient with ataxia and telangiectasia: A case report
por: Nabavizadeh, Sayyed Hesamedin, et al.
Publicado: (2022)

Myoepithelial carcinoma of major salivary glands: Analysis of population-based clinicopathologic and prognostic features
por: Luo, Yunxiu
Publicado: (2022)

Try235Phe homozygous mutation of the steroid 5-a reductase type 2 (SRD5A2) gene in a Turkish patient
por: Parlak, Mesut, et al.
Publicado: (2014)

Identification and validation of EPHX2 as a prognostic biomarker in hepatocellular carcinoma
por: Zhan, Ke, et al.
Publicado: (2021)

Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma
por: Wang, Jianlin, et al.
Publicado: (2018)

METTL5 serves as a diagnostic and prognostic biomarker in hepatocellular carcinoma by influencing the immune microenvironment
por: Wang, Lei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rauth1cioiqradorjjfdhrolg9